Mental health
Mental Health Awareness Week: Medical cannabis and its role in mental health
Sapphire Medical will mark Mental Health Awareness Week by drawing attention to the potential of cannabis in psychological conditions.

Sapphire Medical will mark Mental Health Awareness Week by drawing attention to the potential of cannabis in psychological conditions.
Medical experts will discuss the potential benefits of cannabis for a number of mental health issues in a new video series hosted by Sapphire Medical Clinics.
Mental Health Awareness Week, running from 10-16 May, 2021, is an annual event organised by the Mental Health Foundation to encourage the nation to look after its mental health.
Mental health problems are prevalent across the UK, with 25 percent of the population experiencing a mental health problem of some kind each year and almost 17 percent reporting a common mental health problem in any given week.
While mental health challenges can affect anyone, there are certain groups that experience problems at a higher prevalence, such as ethnic minorities, people with physical health problems, the LGBT+ community, and carers.
Mental health challenges have been exacerbated during Covid-19, with psychological distress worsening more than eight percent on average.
Mental health and medical cannabis
Since November 2018, when medical cannabis was moved to Schedule 2 of the Misuse of Drugs Act, doctors have been prescribing it for a variety of conditions, including anxiety disorders, insomnia, and post-traumatic stress disorder (PTSD)
Medical cannabis is also prescribed for persistent pain, which is thought to impact a quarter of the UK adult population and can have significant impact on wellbeing.
Almost half of those with persistent pain also live with depression and are three times more likely to develop anxiety.
Tackling the stigma
Sapphire Medical’s series has been created to highlight some of the mental health issues individuals are living with, how medical cannabis has helped.
It also features information on Sapphire Medical’s initiatives – such as the Sapphire Foundation and Access Scheme, Sapphire Institute and patient registry – for improving medical cannabis access and education for patients and professionals.
“The continued conversation around mental health is progressing and starting to destigmatise the topic,” commented Dr Mikael Sodergren, managing director at Sapphire Medical.
“Whilst having a conversation is a good starting point, much more needs to be done because mental health issues are not only debilitating for the individuals who suffer from them but also their loved ones and society overall.
“This is why, with this video series, we endeavour to educate everyone about the potential benefits of medical cannabis for mental health so that patients can make informed and educated choices about the treatment they wish to use.”
Get the weekly briefing
A round-up of the latest science, regulation and developments across the UK and Europe — in your inbox every week.
